Blue Owl's earnings missed, and the stock still popped

The earnings miss nobody seemed to panic over

Blue Owl Technology Finance Corp. posted first-quarter adjusted earnings of 29 cents a share, a hair below the 31-cent target on Wall Street’s clipboard. Revenue landed at $325.94 million, also short of the $342.53 million analysts were hoping for.

So why did the stock go up?

Because stocks are rarely polite about making sense. Even with the miss, shares rose 0.9% to $11.73 during the session, suggesting investors either liked the broader setup or decided the miss was more “meh” than “run for the exits.”

The rest of the CNBC cocktail party

The article was really a grab bag of “Final Trades” picks, with Thermo Fisher Scientific and Morgan Stanley tossed into the conversation too. Thermo Fisher was also in the headlines for agreeing to sell its microbiology business to Astorg for about $1.075 billion, while Morgan Stanley was being celebrated for hitting a 52-week high after its own strong first-quarter results.

Big picture

For investors, the key takeaway is that Blue Owl’s numbers were good enough to keep the stock afloat, but not impressive enough to call it a breakout. In other words: not a face-plant, not a victory lap — just another day in the earnings casino.